Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy

P. Jack Hoopes, Alicia A. Petryk, Jennifer A. Tate, Mark S. Savellano, Rendall R. Strawbridge, Andrew J. Giustini, Radu V. Stan, Barjor Gimi, Michael Garwood

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

The predicted success of nanoparticle based cancer therapy is due in part to the presence of the inherent leakiness of the tumor vascular barrier, the so called enhanced permeability and retention (EPR) effect. Although the EPR effect is present in varying degrees in many tumors, it has not resulted in the consistent level of nanoparticle-tumor uptake enhancement that was initially predicted. Magnetic/iron oxide nanoparticles (mNPs) have many positive qualities, including their inert/nontoxic nature, the ability to be produced in various sizes, the ability to be activated by a deeply penetrating and nontoxic magnetic field resulting in cell-specific cytotoxic heating, and the ability to be successfully coated with a wide variety of functional coatings. However, at this time, the delivery of adequate numbers of nanoparticles to the tumor site via systemic administration remains challenging. Ionizing radiation, cisplatinum chemotherapy, external static magnetic fields and vascular disrupting agents are being used to modify the tumor environment/vasculature barrier to improve mNP uptake in tumors and subsequently tumor treatment. Preliminary studies suggest use of these modalities, individually, can result in mNP uptake improvements in the 3-10 fold range. Ongoing studies show promise of even greater tumor uptake enhancement when these methods are combined. The level and location of mNP/Fe in blood and normal/tumor tissue is assessed via histopathological methods (confocal, light and electron microscopy, histochemical iron staining, fluorescent labeling, TEM) and ICP-MS. In order to accurately plan and assess mNP-based therapies in clinical patients, a noninvasive and quantitative imaging technique for the assessment of mNP uptake and biodistribution will be necessary. To address this issue, we examined the use of computed tomography (CT), magnetic resonance imaging (MRI), and Sweep Imaging With Fourier Transformation (SWIFT), an MRI technique which provides a positive iron contrast enhancement and a reduced signal to noise ratio, for effective observation and quantification of Fe/mNP concentrations in the clinical setting.

Original languageEnglish (US)
Title of host publicationEnergy-Based Treatment of Tissue and Assessment VII
Volume8584
DOIs
StatePublished - Jun 10 2013
Event2013 SPIE Conference: Energy-Based Treatment of Tissue and Assessment VII - San Francisco, CA, United States
Duration: Feb 3 2013Feb 4 2013

Other

Other2013 SPIE Conference: Energy-Based Treatment of Tissue and Assessment VII
CountryUnited States
CitySan Francisco, CA
Period2/3/132/4/13

Fingerprint

hyperthermia
Nanoparticles
Blood Vessels
Tumors
Fever
tumors
Imaging techniques
nanoparticles
Neoplasms
Magnetic resonance
imaging techniques
Magnetic Fields
magnetic resonance
augmentation
therapy
permeability
Iron
Permeability
Magnetic fields
microscopy

Keywords

  • EPR effect
  • Imaging
  • Magnetic nanoparticle
  • Tumor vascular modification

Cite this

Hoopes, P. J., Petryk, A. A., Tate, J. A., Savellano, M. S., Strawbridge, R. R., Giustini, A. J., ... Garwood, M. (2013). Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy. In Energy-Based Treatment of Tissue and Assessment VII (Vol. 8584). [858403] https://doi.org/10.1117/12.2008689

Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy. / Hoopes, P. Jack; Petryk, Alicia A.; Tate, Jennifer A.; Savellano, Mark S.; Strawbridge, Rendall R.; Giustini, Andrew J.; Stan, Radu V.; Gimi, Barjor; Garwood, Michael.

Energy-Based Treatment of Tissue and Assessment VII. Vol. 8584 2013. 858403.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Hoopes, PJ, Petryk, AA, Tate, JA, Savellano, MS, Strawbridge, RR, Giustini, AJ, Stan, RV, Gimi, B & Garwood, M 2013, Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy. in Energy-Based Treatment of Tissue and Assessment VII. vol. 8584, 858403, 2013 SPIE Conference: Energy-Based Treatment of Tissue and Assessment VII, San Francisco, CA, United States, 2/3/13. https://doi.org/10.1117/12.2008689
Hoopes PJ, Petryk AA, Tate JA, Savellano MS, Strawbridge RR, Giustini AJ et al. Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy. In Energy-Based Treatment of Tissue and Assessment VII. Vol. 8584. 2013. 858403 https://doi.org/10.1117/12.2008689
Hoopes, P. Jack ; Petryk, Alicia A. ; Tate, Jennifer A. ; Savellano, Mark S. ; Strawbridge, Rendall R. ; Giustini, Andrew J. ; Stan, Radu V. ; Gimi, Barjor ; Garwood, Michael. / Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy. Energy-Based Treatment of Tissue and Assessment VII. Vol. 8584 2013.
@inproceedings{76a587f6cfb84fa8b2a859123a74658f,
title = "Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy",
abstract = "The predicted success of nanoparticle based cancer therapy is due in part to the presence of the inherent leakiness of the tumor vascular barrier, the so called enhanced permeability and retention (EPR) effect. Although the EPR effect is present in varying degrees in many tumors, it has not resulted in the consistent level of nanoparticle-tumor uptake enhancement that was initially predicted. Magnetic/iron oxide nanoparticles (mNPs) have many positive qualities, including their inert/nontoxic nature, the ability to be produced in various sizes, the ability to be activated by a deeply penetrating and nontoxic magnetic field resulting in cell-specific cytotoxic heating, and the ability to be successfully coated with a wide variety of functional coatings. However, at this time, the delivery of adequate numbers of nanoparticles to the tumor site via systemic administration remains challenging. Ionizing radiation, cisplatinum chemotherapy, external static magnetic fields and vascular disrupting agents are being used to modify the tumor environment/vasculature barrier to improve mNP uptake in tumors and subsequently tumor treatment. Preliminary studies suggest use of these modalities, individually, can result in mNP uptake improvements in the 3-10 fold range. Ongoing studies show promise of even greater tumor uptake enhancement when these methods are combined. The level and location of mNP/Fe in blood and normal/tumor tissue is assessed via histopathological methods (confocal, light and electron microscopy, histochemical iron staining, fluorescent labeling, TEM) and ICP-MS. In order to accurately plan and assess mNP-based therapies in clinical patients, a noninvasive and quantitative imaging technique for the assessment of mNP uptake and biodistribution will be necessary. To address this issue, we examined the use of computed tomography (CT), magnetic resonance imaging (MRI), and Sweep Imaging With Fourier Transformation (SWIFT), an MRI technique which provides a positive iron contrast enhancement and a reduced signal to noise ratio, for effective observation and quantification of Fe/mNP concentrations in the clinical setting.",
keywords = "EPR effect, Imaging, Magnetic nanoparticle, Tumor vascular modification",
author = "Hoopes, {P. Jack} and Petryk, {Alicia A.} and Tate, {Jennifer A.} and Savellano, {Mark S.} and Strawbridge, {Rendall R.} and Giustini, {Andrew J.} and Stan, {Radu V.} and Barjor Gimi and Michael Garwood",
year = "2013",
month = "6",
day = "10",
doi = "10.1117/12.2008689",
language = "English (US)",
isbn = "9780819493538",
volume = "8584",
booktitle = "Energy-Based Treatment of Tissue and Assessment VII",

}

TY - GEN

T1 - Imaging and modification of the tumor vascular barrier for improvement in magnetic nanoparticle uptake and hyperthermia treatment efficacy

AU - Hoopes, P. Jack

AU - Petryk, Alicia A.

AU - Tate, Jennifer A.

AU - Savellano, Mark S.

AU - Strawbridge, Rendall R.

AU - Giustini, Andrew J.

AU - Stan, Radu V.

AU - Gimi, Barjor

AU - Garwood, Michael

PY - 2013/6/10

Y1 - 2013/6/10

N2 - The predicted success of nanoparticle based cancer therapy is due in part to the presence of the inherent leakiness of the tumor vascular barrier, the so called enhanced permeability and retention (EPR) effect. Although the EPR effect is present in varying degrees in many tumors, it has not resulted in the consistent level of nanoparticle-tumor uptake enhancement that was initially predicted. Magnetic/iron oxide nanoparticles (mNPs) have many positive qualities, including their inert/nontoxic nature, the ability to be produced in various sizes, the ability to be activated by a deeply penetrating and nontoxic magnetic field resulting in cell-specific cytotoxic heating, and the ability to be successfully coated with a wide variety of functional coatings. However, at this time, the delivery of adequate numbers of nanoparticles to the tumor site via systemic administration remains challenging. Ionizing radiation, cisplatinum chemotherapy, external static magnetic fields and vascular disrupting agents are being used to modify the tumor environment/vasculature barrier to improve mNP uptake in tumors and subsequently tumor treatment. Preliminary studies suggest use of these modalities, individually, can result in mNP uptake improvements in the 3-10 fold range. Ongoing studies show promise of even greater tumor uptake enhancement when these methods are combined. The level and location of mNP/Fe in blood and normal/tumor tissue is assessed via histopathological methods (confocal, light and electron microscopy, histochemical iron staining, fluorescent labeling, TEM) and ICP-MS. In order to accurately plan and assess mNP-based therapies in clinical patients, a noninvasive and quantitative imaging technique for the assessment of mNP uptake and biodistribution will be necessary. To address this issue, we examined the use of computed tomography (CT), magnetic resonance imaging (MRI), and Sweep Imaging With Fourier Transformation (SWIFT), an MRI technique which provides a positive iron contrast enhancement and a reduced signal to noise ratio, for effective observation and quantification of Fe/mNP concentrations in the clinical setting.

AB - The predicted success of nanoparticle based cancer therapy is due in part to the presence of the inherent leakiness of the tumor vascular barrier, the so called enhanced permeability and retention (EPR) effect. Although the EPR effect is present in varying degrees in many tumors, it has not resulted in the consistent level of nanoparticle-tumor uptake enhancement that was initially predicted. Magnetic/iron oxide nanoparticles (mNPs) have many positive qualities, including their inert/nontoxic nature, the ability to be produced in various sizes, the ability to be activated by a deeply penetrating and nontoxic magnetic field resulting in cell-specific cytotoxic heating, and the ability to be successfully coated with a wide variety of functional coatings. However, at this time, the delivery of adequate numbers of nanoparticles to the tumor site via systemic administration remains challenging. Ionizing radiation, cisplatinum chemotherapy, external static magnetic fields and vascular disrupting agents are being used to modify the tumor environment/vasculature barrier to improve mNP uptake in tumors and subsequently tumor treatment. Preliminary studies suggest use of these modalities, individually, can result in mNP uptake improvements in the 3-10 fold range. Ongoing studies show promise of even greater tumor uptake enhancement when these methods are combined. The level and location of mNP/Fe in blood and normal/tumor tissue is assessed via histopathological methods (confocal, light and electron microscopy, histochemical iron staining, fluorescent labeling, TEM) and ICP-MS. In order to accurately plan and assess mNP-based therapies in clinical patients, a noninvasive and quantitative imaging technique for the assessment of mNP uptake and biodistribution will be necessary. To address this issue, we examined the use of computed tomography (CT), magnetic resonance imaging (MRI), and Sweep Imaging With Fourier Transformation (SWIFT), an MRI technique which provides a positive iron contrast enhancement and a reduced signal to noise ratio, for effective observation and quantification of Fe/mNP concentrations in the clinical setting.

KW - EPR effect

KW - Imaging

KW - Magnetic nanoparticle

KW - Tumor vascular modification

UR - http://www.scopus.com/inward/record.url?scp=84878589516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878589516&partnerID=8YFLogxK

U2 - 10.1117/12.2008689

DO - 10.1117/12.2008689

M3 - Conference contribution

SN - 9780819493538

VL - 8584

BT - Energy-Based Treatment of Tissue and Assessment VII

ER -